Effects of nilotinib on platelet function in patients with chronic myeloid leukemia in chronic phase
Background: Tyrosine kinases are highly expressed in platelets and play an important role in their activation process. Some studies have reported the blocking effects of tyrosine kinase inhibitors on different platelet functions. Objectives: Evaluate the effects of nilotinib on platelets aggregation...
Main Authors: | Alauldeen Mudhafar Zubair Alqasim, Ghasaq Mohsin Obaid, Yusra Ghaith Yaseen, Alaa Fadhil Alwan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Leukemia Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048918300074 |
Similar Items
-
Treatment outcome of 100 chronic myeloid leukemia patients using nilotinib as the 2nd line therapy
by: Yaseen M Taher, et al.
Published: (2018-01-01) -
EFFICACY OF NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
by: Sajid Ali, et al.
Published: (2019-12-01) -
EFFICACY OF NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
by: Sajid Ali, et al.
Published: (2019-12-01) -
Development and targeted use of nilotinib in chronic myeloid leukemia
by: Carmen Fava, et al.
Published: (2008-11-01) -
Nilotinib in Chronic Myeloid Leukemia: a comprehensive approach
by: Mario Annunziata
Published: (2015-10-01)